SOURCE: The Medicines Company

The Medicines Company

September 15, 2010 16:30 ET

The Medicines Company to Participate in the UBS Global Life Sciences Conference

PARSIPPANY, NJ--(Marketwire - September 15, 2010) -  The Medicines Company (NASDAQ: MDCO) will present at the UBS Global Life Sciences Conference on Wednesday, September 22nd, in New York, beginning at 2:30pm Eastern Time. Clive Meanwell, President and Chief Executive Officer, will provide a company overview, business update and outlook in the presentation.

The session will be webcast with a link available at The Medicines Company's website www.themedicinescompany.com.

About The Medicines Company
The Medicines Company (NASDAQ: MDCO) is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company markets Angiomax® (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex® (clevidipine butyrate) injectable emulsion in the United States for the reduction of blood pressure when oral therapy is not feasible or not desirable. The Medicines Company's website is www.themedicinescompany.com.

Contact Information